kidney stones and glp-1 Can GLP‑1 medications increase stone risk? A UAB urologist offers insight GLP-1 weight-loss drugs might help

The risks are threefold: a lengthy, career-ending ban from competition due to a doping violation, permanent damage to their reputation, and significant health risks from using unregulated products that may be impure or contaminated

Guo RM, Xu WM, Lin JC, Mo LQ, Hua XX, Chen PX, Wu K, Zheng DD, Feng JQ (2013) Activation of the p38 MAPK/NF-B pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells

R.ZampeseE.WongY

Source: University of Bristol Image Credit: iStock

In obesity care, meaningful has a specific clinical definition: losing at least 5% of starting body weighta threshold associated with health improvements